Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Cancer Research

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 24224123PMCID PMC3816965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Snapshot of Breast Cancer

  2014cited by this paper
• Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas.

  2013cited by this paper
• RKIP: Much more than Raf Kinase inhibitory protein

  2013cited by this paper
• Estrogen receptor signaling as a target for novel breast cancer therapeutics.

  2013cited by this paper
• Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

  2012cited by this paper
• Transcriptional Regulation of RKIP Expression by Androgen in Prostate Cells

  2012cited by this paper
• Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.

  2012cited by this paper
• 1 Polycomb protein EZH 2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer

  2012cited by this paper
• Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

  2012cited by this paper
• Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

  2012cited by this paper
• Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition

  2012cited by this paper
• A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance

  2012cited by this paper
• The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro

  2012cited by this paper
• SnapShot: breast cancer.

  2012cited by this paper
• Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells

  2011cited by this paper
• Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival

  2011cited by this paper
• Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.

  2011cited by this paper
• RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility.

  2011cited by this paper
• Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.

  2011cited by this paper
• Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

  2010cited by this paper
• Molecular stratification of triple-negative breast cancers.

  2010influential reference
• A pathway-based classification of human breast cancer

  2010cited by this paper
• In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models

  2009cited by this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cited by this paper
• Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Breast Cancer

  2009cited by this paper
• Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer

  2008cited by this paper
• Snail is a repressor of RKIP transcription in metastatic prostate cancer cells

  2008cited by this paper
• Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER‐2/neu status

  2008cited by this paper
• Unraveling the complexity of endocrine resistance in breast cancer by functional genomics.

  2008cited by this paper
• The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

  2007cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition

  2007cited by this paper
• Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer.

  2007cited by this paper
• Observer variation in immunohistochemical analysis of protein expression, time for a change?

  2006cited by this paper
• Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

  2006cited by this paper
• Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint.

  2006cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.

  2006cited by this paper
• Genome-wide analysis of estrogen receptor binding sites

  2006cited by this paper
• Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.

  2006cited by this paper
• Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation*

  2005cited by this paper
• Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein

  2005cited by this paper
• Wnt-dependent Regulation of the E-cadherin Repressor Snail*

  2005cited by this paper
• Identification of clinically useful cancer prognostic factors: what are we missing?

  2005cited by this paper
• Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis

  2005cited by this paper
• The Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer

  2004cited by this paper
• RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis*

  2004cited by this paper
• Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

  2003cited by this paper
• MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.

  2003cited by this paper
• Activation of Raf-1 Signaling by Protein Kinase C through a Mechanism Involving Raf Kinase Inhibitory Protein*

  2003cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Mechanism of Suppression of the Raf/MEK/Extracellular Signal-Regulated Kinase Pathway by the Raf Kinase Inhibitor Protein

  2000cited by this paper
• Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

  1999cited by this paper

• Knock-in reporter constructs and drug screening for compounds to restore RKIP expression in cancer.

  2026cites this paper
• The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune Evasion.

  2026cites this paper
• Role of microRNAs in the regulation of RKIP and signaling pathways in cancer.

  2025cites this paper
• The implied dysregulated RKIP-hypoxia axis in cancer and immune evasion: Clinical implications.

  2025cites this paper
• TGF-β and TNF-α interaction promotes the expression of MMP-9 through H3K36 dimethylation: implications in breast cancer metastasis

  2024cites this paper
• Circulating RKIP and pRKIP in Early-Stage Lung Cancer: Results from a Pilot Study

  2024cites this paper
• Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications

  2023influential citation
• Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools

  2022influential citation
• RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity

  2021cites this paper
• Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance

  2020cites this paper
• Tumor hypoxic stress, cellular plasticity and RKIP

  2020cites this paper
• A review of RKIP promotion of tumor progression, metastasis and poor outcome in multiple solid tumor types

  2020cites this paper
• Implications of RKIP protein in cancer prognosis and therapy response: A literature update

  2020cites this paper
• RKIP & GSK3β: The interaction of two intracellular signaling network regulators and their role in cancer

  2020cites this paper
• Anti-cancer effect of RKIP via modulating autophagy during metastasis

  2020cites this paper
• Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling

  2019cites this paper
• RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact

  2018cites this paper
• Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors

  2018cites this paper
• Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog)

  2017cites this paper
• Reduced RKIP Expression is Associated With Breast Neoplastic Progression and is Correlated With Poor Outcomes and Aberrant Methylation in Breast Carcinoma

  2017cites this paper
• Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma

  2016influential citation
• BACH1, the master regulator gene: A novel candidate target for cancer therapy.

  2016cites this paper
• β-Secretase 1’s Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice

  2016cites this paper
• Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity

  2015cites this paper
• RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13

  2015cites this paper
• Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells.

  2015influential citation
• RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration

  2015cites this paper
• Promoter methylation of Raf kinase inhibitory protein: A significant prognostic indicator for patients with gastric adenocarcinoma

  2014cites this paper
• Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer.

  2014cites this paper
• Raf kinase inhibitory protein (RKIP) suppresses tumor cell invasion and metastasis. In the present study, the associations between RKIP protein expression and promoter methylation with clinicopathological parameters, prognosis and survival rates in gastric adenocarcinoma were investigated. RKIP prot

  2014cites this paper